University of South Florida

Natura Therapeutics, Inc.

Brian Nelson Giunta

Jun Tan

Paul R Sanberg

Roland Douglas Shytle

Adam John Smith

Cyndy Davis Sanberg

Song Li

Huayan Hou

The present invention provides fusion peptides, compositions, methods and kits for treating, reducing the risk of, lessening the severity of, preventing, or delaying the onset of amyloid-related disorders, such as Alzheimer's disease and HIV associated neurocognitive impairment.

Amyloid precursor protein (APP) based &#xc3;#-secretase inhibitor peptides, and methods of use

Compositions and methods of increasing the bioavailability of catechins are presented. Compositions for increasing the bioavailability of catechins include compositions where the catechin is added to a solution of ethanol and water; compositions where the catechin is encapsulated within a nanoparticle; and compositions in which a nanoparticle complex is formed between the catechin and the nanoparticle. Each of these compositions was shown to increase bioavailability of EGCG and is useful in treating diseases such as Alzheimer's and HIV-associated dementia.

Methods and compositions for improving bioavailability of epigallocatechin gallate (EGCG)

Growing community of inventors

Tampa, FL, United States of America

Brian Nelson Giunta